Glucose-dependent Insulinotropic Polypeptide Receptor

From Proteopedia

Jump to: navigation, search

Glucose-dependant

Drag the structure with the mouse to rotate

3D structures of GIPR

Updated on 25-June-2024

7fiy – hGDIPR (mutant) + gastric inhibitory polypeptide + guanine nucleotide-binding protein – human – Cryo EM
7ra3, 7rbt – hGDIPR + gastric inhibitory polypeptide + guanine nucleotide-binding protein + nanobody + ScfV – Cryo EM
7dty, 7fin, 7vab – hGDIPR (mutant) + gastric inhibitory polypeptide + guanine nucleotide-binding protein + nanobody – Cryo EM
2qkh - hGDIPR extracellular domain 29-138 + GIP
4hj0, 6dkj - hGDIPR extracellular domain + antibody
6o9h, 6o9i - mGDIPR extracellular domain + antibody - mouse

References

  1. Lynn FC, Thompson SA, Pospisilik JA, Ehses JA, Hinke SA, Pamir N, McIntosh CH, Pederson RA. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells. FASEB J. 2003 Jan;17(1):91-3. Epub 2002 Nov 15. PMID:12475913 doi:10.1096/fj.02-0243fje
  2. Lynn FC, Pamir N, Ng EH, McIntosh CH, Kieffer TJ, Pederson RA. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. Diabetes. 2001 May;50(5):1004-11. PMID:11334402
  3. "Byetta." BYETTA (exenatide) Injection | Welcome to BYETTA.com. Amylin Pharmaceuticals, Inc., 2011. Web. 02 Dec. 2011. <http://www.byetta.com/Pages/index.aspx>

See Also

Personal tools